These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1462980)

  • 41. Medical management of nephropathy in type I diabetes mellitus: current recommendations.
    Breyer JA
    J Am Soc Nephrol; 1995 Dec; 6(6):1523-9. PubMed ID: 8749676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The renal hemodynamic basis of diabetic nephropathy.
    O'Bryan GT; Hostetter TH
    Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current issues in the diagnosis and therapy of diabetic nephropathy].
    de Châtel R; Mogyorósi A; Ziyadeh FN
    Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin-dependent diabetes mellitus and hypertension.
    Nosadini R; Fioretto P; Trevisan R; Crepaldi G
    Diabetes Care; 1991 Mar; 14(3):210-9. PubMed ID: 2044436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS
    Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
    Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
    Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes.
    Miller JA; Scholey JW; Thai K; Pei YP
    Kidney Int; 1997 Jan; 51(1):119-24. PubMed ID: 8995725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural history of diabetic complications: early detection and progression.
    Deckert T; Feldt-Rasmussen B; Borch-Johnsen K; Jensen T; Kofoed-Enevoldsen A; Mathiesen ER
    Diabet Med; 1991; 8 Spec No():S33-7. PubMed ID: 1825954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria.
    De Cosmo S; Bacci S; Piras GP; Cignarelli M; Placentino G; Margaglione M; Colaizzo D; Di Minno G; Giorgino R; Liuzzi A; Viberti GC
    Diabetologia; 1997 Oct; 40(10):1191-6. PubMed ID: 9349601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prolactin secretion in diabetic nephropathy of patients with diabetes mellitus type I (IDDM)].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gumprecht J
    Pol Arch Med Wewn; 1996 Feb; 95(2):125-34. PubMed ID: 8677206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
    Andrésdóttir G; Bakker SJ; Hansen HP; Parving HH; Rossing P
    Diabet Med; 2013 May; 30(5):563-6. PubMed ID: 23324103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etiology, diagnosis, and prevention of renal involvement in insulin-dependent diabetes mellitus.
    Chiumello G; Beccaria L; Meschi F; Mistura L; Brambilla P; Bognetti E
    Pediatrician; 1983-1985; 12(4):199-207. PubMed ID: 6400450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SGLT2 Inhibitors and the Diabetic Kidney.
    Fioretto P; Zambon A; Rossato M; Busetto L; Vettor R
    Diabetes Care; 2016 Aug; 39 Suppl 2():S165-71. PubMed ID: 27440829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Albuminuria in nondiabetic relatives of IDDM patients with and without diabetic nephropathy.
    Fagerudd JA; Pettersson-Fernholm KJ; Riska MK; Grönhagen-Riska C; Groop PH
    Kidney Int; 2000 Sep; 58(3):959-65. PubMed ID: 10972659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium antagonists and the diabetic hypertensive patient.
    Parving HH; Rossing P
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):47-52. PubMed ID: 8503435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
    Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical profile of Japanese dialysis patients with diabetic nephropathy, diagnosed as having diabetes before the age of thirty.
    Takahashi C; Nagai N; Ujihara N; Babazono T; Nakanishi K; Yokoyama H; Sanaka T; Hirata Y
    Diabetes Res Clin Pract; 1990 Oct; 10(2):127-31. PubMed ID: 2261848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.